For Patients
Inobrodib is a first-of-its-kind investigational treatment for multiple myeloma and other cancers.
Eligibility for enrollment in an inobrodib clinical trial is made by oncologists at participating clinical trial sites, and not by CellCentric. Any advice on clinical study options should come from your doctor.
Christina's Story
Latest press releases
